Lorus Therapeutics Inc. (LRP) Reports First Quarter Results for Fiscal Year 2010
10/6/2009 10:51:13 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Publication Supporting Novel Mode of Anticancer Therapy for LOR-253 Class of Compounds
9/21/2009 11:19:07 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Allowance of Patent for LOR-2040 in Japan
8/5/2009 10:40:20 AM
More...
|
Lorus Therapeutics Inc. (LRP) Reports Results for Fiscal Year 2009
7/27/2009 9:46:25 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Publication of a Novel Analytical Method Confirming the Pharmacological Action of Its Anticancer Drug LOR-2040
6/29/2009 11:12:14 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Settlement of Secured Convertible Debentures
6/23/2009 11:26:01 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces a Cooperative Research and Development Agreement With the U.S. National Cancer Institute
5/19/2009 11:13:04 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Presentation of New Supportive Data for LOR-2040 in Acute Myeloid Leukemia
4/22/2009 11:00:36 AM
More...
|
Lorus Therapeutics Inc. (LRP) Presents New Findings for First-in-class Anticancer Drug Candidate LOR-253
4/20/2009 10:54:14 AM
More...
|
Lorus Therapeutics Inc. (LRP) Announces Report of Evidence of Clinical Activity in Clinical Trial of LOR-2040 Combined With Capecitabine and Oxaliplatin in the Treatment of Advanced Metastatic Solid Tumors
4/15/2009 10:38:23 AM
More...
|
|